Close

Bristol-Myers Squibb Co. (BMY): Execution Risk Higher - BMO

January 20, 2017 7:15 AM EST Send to a Friend
BMO Capital analyst, Alex Arfei, reiterated his Market Perform rating on share of Bristol-Myers Squibb Co. (NYSE: BMY) after Bristol's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login